• Home
  • RA2Day Anniversary Special rescheduled


Zwiers feels it is appropriate to reschedule this event because of the COVID situation and related governmental advice. We will be sure to inform you on the new date.

In the meantime…check out the programme: looking forward to meeting you!” 



Overview of a decade of new oncology drugs


  • Regulatory approvals: cancer drugs reaching the market

  • EU vs US: difference in approval times

  • Impact of clinical development time on approval


  • Regulatory toolbox: opportunities for faster approval

  • Advisory Committee Meeting (US) vs Scientific Advisory Group (EU)


Click here for the full programme